Determination of the antifungal agent voriconazole in human plasma using a simple column-switching high-performance liquid chromatography and its application to a pharmacokinetic study.

A simple column-switching high performance liquid chromatographic (HPLC) method that does not require any complicated pretreatment has been developed to determine voriconazole in human plasma samples. An internal standard (IS) and borate buffer (pH 9.0) were added to plasma samples, which were then injected directly into the column-switching HPLC system using MAYI-ODS as a pre-column. The calibration curve for voriconazole showed good linearity in the range of 0.2-10 mug/ml in human plasma. The mean RSD (%) value of intra-day (n=6) and inter-day (n=5) precision were less than 5.4% and 8.2%, respectively. This system could make more than three hundred successive, accurate measurements when a washing step with ammonium acetate solution was added. This method was successfully applied to measure the therapeutic voriconazole level in patients' plasma, and was used in a study of voriconazole pharmacokinetics after oral administration.

[1]  T. Buclin,et al.  Variability of Voriconazole Plasma Levels Measured by New High-Performance Liquid Chromatography and Bioassay Methods , 2006, Antimicrobial Agents and Chemotherapy.

[2]  Hea‐Young Cho,et al.  Direct and simultaneous analysis of loxoprofen and its diastereometric alcohol metabolites in human serum by on-line column switching liquid chromatography and its application to a pharmacokinetic study. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  S. Krähenbühl,et al.  Fast and reliable determination of the antifungal drug voriconazole in plasma using monolithic silica rod liquid chromatography. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  J. Mehta,et al.  Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients , 2005, Bone Marrow Transplantation.

[5]  B. Bannwarth,et al.  Direct injection HPLC micro method for the determination of voriconazole in plasma using an internal surface reversed-phase column. , 2004, Biomedical chromatography : BMC.

[6]  A. Caputi,et al.  Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population. , 2004, Pharmacological research.

[7]  M. Rinaldi,et al.  Development and Validation of a High-Performance Liquid Chromatography Assay for Voriconazole , 2003, Antimicrobial Agents and Chemotherapy.

[8]  C. A. Kauffman,et al.  Voriconazole: a new triazole antifungal agent. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  N. Wood,et al.  Pharmacokinetics and Safety of Voriconazole following Intravenous- to Oral-Dose Escalation Regimens , 2002, Antimicrobial Agents and Chemotherapy.

[10]  H. Lazarus,et al.  Safety and Pharmacokinetics of Oral Voriconazole in Patients at Risk of Fungal Infection: A Dose Escalation Study , 2002, Journal of clinical pharmacology.

[11]  Y. Ishihama,et al.  Methylcellulose-immobilized Reversed-phase Precolumn for Direct Analysis of Drugs in Plasma by HPLC , 2001, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[12]  T. Patterson.  Role of newer azoles in surgical patients. , 1999, Journal of chemotherapy.

[13]  D. Sheehan,et al.  Current and Emerging Azole Antifungal Agents , 1999, Clinical Microbiology Reviews.

[14]  D. Stopher,et al.  Determination of a new antifungal agent, voriconazole, by multidimensional high-performance liquid chromatography with direct plasma injection onto a size-exclusion column. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[15]  T Ishizaki,et al.  Genotyping of S‐mephenytoin 4′‐hydroxylation in an extended Japanese population , 1996, Clinical pharmacology and therapeutics.

[16]  V. Andriole,et al.  Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis , 1996, Antimicrobial agents and chemotherapy.

[17]  M. Vogeser,et al.  Quantification of voriconazole in plasma by liquid chromatography-tandem mass spectrometry , 2005, Clinical chemistry and laboratory medicine.